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Abstract 15 
Obesity remains a major public health concern and intermittent fasting is a popular strategy 16 
for weight-loss, which may present independent health benefits. However, the number of diet 17 
books advising how fasting can be incorporated into our daily lives is several orders of 18 
magnitude greater than the number of trials examining whether fasting should be encouraged 19 
at all. This review will consider the state of current understanding regarding various forms of 20 
intermittent fasting (e.g. 5:2, time-restricted feeding and alternate-day fasting). The efficacy 21 
of these temporally defined approaches appears broadly equivalent to that of standard daily 22 
calorie restriction, although many of these models of intermittent fasting do not involve fed-23 
fasted cycles every other 24-h sleep-wake cycle and/or permit some limited energy intake 24 
outside of prescribed feeding times. Accordingly, the intervention period therefore may not 25 
regularly alternate, may not span all or even most of any given day, and may not even 26 
involve absolute fasting. This is important because potentially advantageous physiological 27 
mechanisms may only be initiated if a post-absorptive state is sustained by uninterrupted 28 
fasting for a more prolonged duration than applied in many trials. Indeed, promising effects 29 
on fat mass and insulin sensitivity have been reported when fasting duration is routinely 30 
extended beyond 16 consecutive hours. Further progress will require such models to be tested 31 
with appropriate controls to isolate whether any possible health effects of intermittent fasting 32 
are primarily attributable to regularly protracted post-absorptive periods, or simply to the net 33 
negative energy balance indirectly elicited by any form of dietary restriction.  34 
Background 35 
Obesity is a prevalent health concern throughout the world (1,2), which arises due to chronic 36 
positive energy balance (3–5). Any energy surplus is stored primarily in the form of 37 
triglycerides within adipocytes, thus leading to adipose tissue expansion (6,7) predominantly 38 
as a result of adipocyte hypertrophy (8). If sustained over time, this hypertrophic expansion 39 
can lead to adipocyte dysfunction, hyperglycaemia, hyperlipidaemia, ectopic lipid deposition, 40 
chronic low-grade systemic inflammation and insulin resistance (9–15), thereby fostering 41 
comorbidities such as type 2 diabetes and cardiovascular disease (16,17). To remedy this 42 
metabolic dysfunction, interventions often seek to redress the underlying energy imbalance 43 
by reducing energy intake and/or increasing expenditure, which can improve health outcomes 44 
(18,19). However, these improvements are hampered by compensatory changes in appetite 45 
and energy use (4,20–22), as well as poor adherence (23,24), resulting in poor long-term 46 
success rates (4,25,26). 47 
Strategies that exploit nutrient timing as a means of achieving weight loss and/or improving 48 
metabolic health have been the subject of considerable public interest in recent years (27). 49 
Intermittent fasting is an umbrella term that may be used to describe these approaches, which 50 
involve a complete or partial restriction of energy within defined temporal windows on a 51 
recurrent basis (27,28). Thus far, the therapeutic potential of intermittent fasting has been 52 
largely overshadowed by direct manipulation of the principal components of the energy 53 
balance equation (29). However, advances in the understanding of circadian rhythms suggest 54 
that this could be a particularly effective approach for tackling obesity and the accompanying 55 
dysfunction (30,31), in addition to arguably being more acceptable in practice than 56 
conventional alternatives (32–36). To explore this notion, this review will consider the 57 
literature on meal timing and intermittent fasting as it relates to metabolic health. 58 
Meal Timing 59 
In Western cultures, a pattern of three or more meals per day is generally accepted as a 60 
societal norm (37,38). However, this typically results in an anabolic state predominating each 61 
day (39,40). The postprandial metabolic response to a mixed-macronutrient meal in 62 
metabolically healthy participants is characterised by a peak in glycaemia within the first 63 
hour followed by a steady return to fasted glycaemia over the ensuing two hours (41,42). This 64 
is paralleled by an accompanying peak in insulin secretion within the first hour followed by a 65 
decrease over the next 4 hours (42). Conversely, plasma triglyceride concentrations rise 66 
steadily to a peak after 3-5 hours and generally remain 50% higher than baseline even after 6 67 
hours (41). When a subsequent meal is ingested approximately five hours after the first (as is 68 
common in Western diets), glucose peaks at a similar time after feeding, albeit an attenuated 69 
absolute peak (43). However, glucose then takes slightly longer to return to baseline as the 70 
day progresses, a pattern that is largely mirrored by insulin concentrations (44). Plasma 71 
triglycerides on the other hand do not reach their peak following the first meal until shortly 72 
after the second meal is ingested, then fall rapidly due to the insulinaemic response to the 73 
second meal, before peaking again around 5 hours after the second meal (44).  74 
These responses suggest that, even with just two meals per day, plasma triglycerides are 75 
elevated continuously for 12 hours, with this pattern then propagated when further extended 76 
to include a third meal. This is well-demonstrated by Ruge et al. (45), who examined the 24-77 
hour circulating profiles of glucose, triglycerides and insulin in response to three successive 78 
meals at 10:00, 15:00 and 20:00. Within this model, triglycerides remained elevated until 79 
02:00, along with insulin and glucose concentrations. Similarly, McQuaid et al. (46) showed 80 
that triglyceride extraction by adipose tissue in response to three meals per day is elevated for 81 
over 16 hours. The net effect of this is that the majority of each 24-h day is spent in a 82 
postprandial and lipogenic state, which is conducive to fat accretion (39,40). By extension, 83 
this provides fewer opportunities for net lipolysis and the predominance of lipid-derived 84 
substrates in energy metabolism, thereby favouring positive fat balance. 85 
Ultimately, this results in a scenario wherein those adhering to conventional dietary meal 86 
timing patterns are attempting to achieve energy balance using a feeding schedule that is 87 
inherently biased toward fat accretion. Conventional diet and exercise interventions aim to 88 
reduce the amplitude of postprandial excursions in order to provide more opportunities for 89 
the liberation and utilisation of endogenous lipid reservoirs. However, the imbalance between 90 
the daily fasting window and the daily feeding window remains largely unperturbed. 91 
Comparatively, the omission of meals is typically necessitated by intermittent fasting and 92 
eliminates a subset of these postprandial excursions, thereby providing greater equilibrium 93 
between fasting and feeding opportunities and a better platform for achieving energy balance. 94 
Further to this, the routine extension of fasting periods has been associated with metabolic 95 
benefits which are independent of net energy balance (27,28,47), constituting a secondary 96 
therapeutic dimension to these strategies. Specifically, Anton et al. (28) argue that the 97 
depletion of hepatic glycogen reserves and the ensuing transition toward metabolism of 98 
endogenous, lipid-derived substrates (i.e. non-esterified fatty acids, glycerol, ketone bodies), 99 
prompts a series of adaptive processes conducive to improved health outcomes, including 100 
improvements in body composition and insulin sensitivity. Considering that this transition 101 
does not take place in most instances until the uninterrupted fasting duration proceeds beyond 102 
12-14 hours (28,48), these adaptive processes are not often invoked by the conventional meal 103 
patterns described above. 104 
Based on the above reasoning, it is conceivable that intermittent fasting may constitute an 105 
efficacious strategy for tackling obesity and the metabolic disorders associated with excess 106 
adiposity. To date, however, studies exploring these facets of intermittent fasting are scarce 107 
and inconsistent.  108 
Eating Frequency 109 
Perhaps the most widely researched dimension of nutrient timing within the context of 110 
obesity in humans is eating frequency. Early work by Fabry et al. (49) deployed a cross-111 
sectional approach to explore the relationship between intake frequency and metabolic health. 112 
Interestingly, in a cohort of 440 men, higher eating frequency broadly corresponded to a 113 
healthier profile of body mass index (BMI), cholesterol concentrations and fasting glucose. 114 
Contrary to this, using data from NHANES, Murakami and Livingstone (50) observed that 115 
those eating on more than four occasions per day were approximately 50% more likely to be 116 
overweight or obese by BMI relative to those eating on less than three occasions per day. 117 
Such discrepancies are a consistent theme throughout these cross-sectional studies; a recent 118 
systematic review by Canuto et al. (51) analysed data from 31 such studies containing a 119 
collective sample of over 130,000 participants. Of these 31 studies, 14 established an inverse 120 
association, 10 showed no association, and 7 revealed a positive association, which the 121 
authors ascribe to the spectrum of approaches employed.    122 
Upon shifting to prospective methodologies, the pattern appears to be largely the same; two 123 
recent systematic reviews conclude that the majority of studies reveal no association between 124 
eating frequency and subsequent obesity (52,53). The review of Raynor et al. (52) makes a 125 
particularly strong case, given that these authors only included human studies in which food 126 
was provided or intake monitored in a laboratory setting. However, of the studies covered in 127 
these reviews, most evaluated the impact of increased meal frequency on metabolic health, 128 
wherein three meals per day is used as the reference for lower frequency. Therefore, upon 129 
framing these studies within the context of the 24-hour metabolite profiles discussed 130 
previously, the lack of a consensus is perhaps not surprising. In fact, only one of the studies 131 
reported is likely to have resulted in the predominance of a fasting state over the course of 24 132 
hours (54). 133 
Specifically, the study of Stote et al. (54) explored the impact of reducing meal frequency to 134 
one meal per day under conditions of energy balance. Briefly, 15 normal-weight participants 135 
completed two 8-week intervention periods in a randomised crossover design with an 11-136 
week washout interval. In one treatment, all calories were consumed in a single meal between 137 
17:00 and 21:00, whilst the other treatment separated the same foods into a conventional 138 
breakfast, lunch and dinner format. To facilitate compliance, the dinner in both conditions 139 
was consumed under supervision and all foods were provided. The diets were matched for 140 
both energy and macronutrient content and targeted weight maintenance, with daily 141 
adjustment of prescribed intake based on body weight measurements, which were then 142 
mirrored in the opposing trial. No differences in body mass, body composition or health 143 
markers were apparent at the outset of each treatment and no differences in energy intake, 144 
macronutrient balance or physical activity were noted between the two conditions. Despite 145 
these null findings, body mass and fat mass (as assessed by bioelectrical impedance) were 146 
reduced by 1.4 kg and 2.1 kg, respectively, following the one meal per day condition but not 147 
the three meals per day condition. However, the reduction in adiposity was not accompanied 148 
by improvements in lipid profile or glycaemia (55). This is consistent with the prior 149 
suggestion that extending the daily fasting period may result in increased utilisation of lipid-150 
derived substrates in energy metabolism and favourable effects on fat balance (28). 151 
The above interpretation suggests that, in much the same way as a protracted daily feeding 152 
window may be conducive to an energy surplus, prolonged fasting on a routine basis could be 153 
an effective strategy to counter fat accretion. However, what is particularly interesting here is 154 
that this observation was made under carefully matched conditions. Whilst this does not 155 
exclude any possibility of some amalgamation of undetectable changes in the various 156 
components of energy balance (56), it is also plausible that the protracted fasting period is 157 
exerting impacts on energy metabolism that are independent of net energy balance (28,57). 158 
The current literature on intermittent fasting provides a useful platform for exploring this 159 
notion further. 160 
Intermittent Fasting 161 
The umbrella term intermittent fasting refers to a series of therapeutic interventions which 162 
target temporal feeding restrictions, nominally categorised as: the 5:2 diet, modified 163 
alternate-day fasting, time-restricted feeding and complete alternate-day fasting (27). 164 
Irrespective of the rationale for each, such approaches have been subject to growing 165 
popularity in recent years, yet experimental data to support their application is comparatively 166 
sparse (27,36). Bluntly, the number of diet books advising how intermittent fasting can be 167 
incorporated into our daily lives is several orders of magnitude greater than the number of 168 
scientific papers examining whether intermittent fasting should be encouraged at all (27). 169 
The 5:2 Diet – Amongst the most coveted forms of intermittent fasting is the 5:2 diet, 170 
wherein severe energy restriction is imposed on two days per week with ad libitum 171 
consumption on the remaining five. The study of Carter, Clifton and Keogh (58) randomised 172 
63 adults with overweight or obesity and type 2 diabetes to 12 weeks of either daily calorie 173 
restriction or a 5:2 approach. The 5:2 group reduced their intake to 400-600 kcal for two non-174 
consecutive days per week and followed their habitual diet on the remaining five, whilst the 175 
daily restriction group simply reduced their intake to 1200-1550 kcal everyday. Although the 176 
extent to which prescriptions were achieved was not reported, main effects of time but not 177 
group were seen for reductions in body mass, fat mass and fat-free mass, as well as 178 
improvements in glycated haemoglobin concentration and the use of diabetic medications. 179 
Similar conclusions were also drawn by two recent studies which compared this 5:2 approach 180 
(i.e. 400-600 kcal∙day-1 on two non-consecutive days per week) against daily energy 181 
restriction over 6 months (59,60). 182 
This pattern of results indicates a broad equivalency between the metabolic impacts of the 5:2 183 
diet versus daily calorie restriction, arguing against any special properties of the fasting 184 
element per se. However, this is not a consistent finding throughout the literature. Upon 185 
comparing the 5:2 approach (requiring two consecutive days of 75% calorie restriction per 186 
week) against daily calorie restriction (requiring 25% calorie restriction everyday) over six 187 
months, Harvie et al. (61) observed differential changes in fasting insulin and fasting indices 188 
of insulin resistance. Despite similar reductions in body mass and fat mass, the modest 189 
reductions in fasting insulin and insulin resistance seen in both groups were more pronounced 190 
with the 5:2 method. Although this may reflect a more potent influence of using two 191 
consecutive days of severe energy restriction (as opposed to non-consecutive), there were 192 
also greater reductions in energy and carbohydrate intake in this group, which complicate the 193 
interpretation.  194 
Using a similar approach, Antoni et al. (62) sought to compare the effects of intermittent 195 
energy restriction (implemented using the 5:2 approach) against daily calorie restriction when 196 
matched for net energy balance and thus weight losses, in order to minimise the confounding 197 
influence of such factors on metabolic health. Furthermore, this study featured dynamic 198 
indices of metabolic control, building upon the prior studies which only featured fasted 199 
measures. Briefly, 27 participants with overweight or obesity were randomised to undertake 200 
either an intermittent or a continuous energy restriction diet. The 5:2 condition restricted 201 
participants to 630 kcal∙day-1 for two consecutive days each week, with a self-selected 202 
eucaloric diet on the remaining five. Comparatively, the continuous restriction implemented a 203 
self-selected diet intended to reduce energy intake by 600 kcal∙day-1. As opposed to returning 204 
to the laboratory after a fixed period, participants were reassessed upon achieving a 5% 205 
weight loss. Despite larger reductions in energy intake in the intermittent condition, the 206 
design meant that changes in body mass were similar between groups. Body composition and 207 
fasting biochemical outcomes were also similarly affected by the two diets, showing good 208 
agreement with previous studies. However, the intermittent diet resulted in significant 209 
reductions in postprandial triglyceride concentrations relative to daily calorie restriction, 210 
whilst postprandial C-peptide concentration also showed a tendency for greater reductions in 211 
the intermittent feeding group.  The authors concluded that this highlights a potential 212 
superiority of intermittent relative to continuous energy restriction. 213 
Based on the above studies of the 5:2 approach to intermittent fasting, it seems that the 214 
manner in which the fast is applied is a key determinant of the impacts on metabolic health. 215 
When the fast is undertaken on consecutive days, there is an apparent superiority relative to 216 
daily calorie restriction (61,62), whilst applying the fast on non-consecutive days results in 217 
broadly equivalent effects (58–60). Upon considering this in terms of the resultant 218 
uninterrupted fasting duration, this would appear to fit with the proposition of Anton et al. 219 
(28), as fasting on consecutive days is more likely to result in an uninterrupted fast of over 220 
12-14 hours when compared to fasting on non-consecutive days. However, as these 221 
interventions do not confine the permitted intake during fasting to a specific time window 222 
(e.g. 400-600 kcal consumed between 12:00 and 14:00 on fasting days), this makes it difficult 223 
to establish the exact duration of absolute fasting achieved. 224 
Modified Alternate-Day Fasting – The majority of human studies which examine 225 
intermittent fasting have centred upon a strategy referred to as modified alternate-day fasting 226 
(27). It differs from the 5:2 diet in two key regards: the severe restriction is applied during 227 
alternating days (nominally 24 hours, although practically more varied to accommodate 228 
sleep); and any permitted calories during ‘fasting’ are provided as a single meal (thereby 229 
ensuring a tangible extension of the typical overnight fast). Much of the work undertaken in 230 
this field originates from pioneering experiments by Varady and colleagues, in which 231 
participants were required to alternate between 24-hour periods of fasting and ad libitum 232 
feeding, with a single 600-800 kcal meal permitted between 12:00 and 14:00 on non-feeding 233 
days. 234 
The effects of this approach on body mass were initially explored by Varady et al. (32) in a 235 
single-arm trial, where 12 obese participants completed 8 weeks of modified alternate-day 236 
fasting. Reported adherence to the fasting protocol remained high throughout, with energy 237 
intake averaging 26% of habitual (32,35). Comparatively, intake on feeding days reached 238 
95% of the habitual level, resulting in a 37% net calorie restriction on average. This led to 239 
body mass losses of 5.6 kg, 5.4 kg of which was accounted for by decreases in fat mass (32). 240 
Total cholesterol, LDL cholesterol and triglycerides were also reduced by at least 20%, 241 
effects which were associated with improvements in adipokine profile (63). Subsequent work 242 
by the same group neatly demonstrates that these outcomes are similar when applied to 243 
cohorts of adults who are overweight (64), when meal timing on the fasting day can be varied 244 
(65), and that concurrent macronutrient manipulation does not exert additive effects (66). 245 
Collectively, these data suggest that modified alternate-day fasting may be a viable means of 246 
improving cardiometabolic health in adults who are overweight or obese. However, without a 247 
comparative daily calorie restriction group it is difficult to isolate any independent effects of 248 
the fasting periods from the effects of energy restriction and/or associated weight loss. This 249 
was addressed recently by a comparison of the two methods under isocaloric conditions 250 
relative to a no intervention control group (67,68). Briefly, 69 adults with obesity were 251 
randomised to undertake 6 months of modified alternate-day fasting or daily calorie 252 
restriction. The alternate day fasting diet restricted participants to a single meal containing 253 
25% of their measured energy requirements between 12:00 and 14:00 during fasting periods, 254 
but prescribed 125% of energy requirements on feeding days. Conversely, the daily calorie 255 
restriction diet prescribed a 25% reduction in energy intake every day, resulting in an 256 
equivalent reduction in energy intake of 25% in both groups. Macronutrient balance was 257 
preserved in both instances and the attained calorie restriction was 21% and 24% for 258 
alternate-day fasting and daily calorie restriction, respectively. The observed body mass loss 259 
of 6.8 % was also similar between the two groups, a pattern driven by changes in both fat 260 
mass and lean mass. Fasted markers of metabolic health were also largely unaffected by 261 
either intervention, including lipid profile, inflammatory markers, adipokines, glucose 262 
concentration and insulin resistance (67,68). Furthermore, few differences emerged during an 263 
ensuing 6-month weight maintenance period in which the feeding patterns were maintained 264 
but the prescriptions modified to fulfil energy requirements (i.e. no energy deficit). 265 
This once again indicates that intermittent fasting and daily calorie restriction exert similar 266 
effects on most health outcomes, as concluded previously for the 5:2 approach. However, 267 
during the modified alternate-day fasting intervention, participants consistently over-268 
consumed on fasting days and under-consumed on fed days, in what the authors describe as 269 
de facto calorie restriction (67). Consequently, over the duration of the study the difference in 270 
reported energy intake between feeding and fasting days was less than 500 kcal on average 271 
(69). Yet when the 34 participants that undertook alternate-day fasting were stratified into 272 
those who lost more versus less than 5% body mass, those closest to the prescribed intake 273 
targets showed larger decreases in body mass despite consuming more calories overall (69). 274 
Unfortunately, the mechanisms underpinning this are unclear. The observation could reflect 275 
increased use of lipid-derived substrates or lower levels of adaptive thermogenesis with 276 
intermittent methods, or perhaps it simply reflects poorer dietary reporting by those with 277 
lower adherence.  278 
Nonetheless, data emerging from studies of modified alternate-day fasting do not allude to a 279 
superiority relative to daily calorie restriction. Although, the use of single-arm trials and poor 280 
adherence to fasting prescriptions leave this question open to further study. 281 
Time-Restricted Feeding – Ironically, the adherence issues that appear common to modified 282 
alternate-day approaches may lie in the imposition of a severe restriction as opposed to a 283 
complete fast, which in being an absolute (albeit more severe) could in fact facilitate 284 
compliance (32,33,36). Drawing from this premise, time-restricted feeding is another method 285 
of intermittent fasting which has emerged recently (27) and requires no knowledge of food 286 
composition or restraint at eating occasions, only awareness of the time at which eating 287 
occasions are permitted at all. This approach aims to restrict food intake to a temporal 288 
window (typically ≤10 h) within the waking phase, thereby reducing feeding opportunities 289 
and extending the overnight fast to at least 14 hours per day (70).  290 
Work in our laboratory explored the impact of extending the overnight fast on energy balance 291 
and nutrient metabolism, thereby providing several insights regarding the effects of such 292 
strategies (71–74). Initially, 33 adults who were of healthy weight were randomised to 6 293 
weeks of either consuming breakfast, defined as at least 700 kcal before 11:00 daily (with 294 
half consumed within 2 hours of waking), or extended morning fasting up until 12:00 (73). 295 
Interestingly, improvements in anthropometric parameters and fasting health markers were 296 
not meaningfully different between interventions. In agreement, a panel of hormones 297 
implicated in the regulation of energy balance showed little change following the two 298 
interventions, although specific measures of adipose tissue insulin sensitivity suggested an 299 
improvement in the breakfast group only (71). 300 
These largely null findings relative to prior research could be explained by the free-living 301 
approach used to study compensatory changes in components of energy balance. The fasting 302 
group consumed fewer calories than the breakfast group when averaged throughout each 24-303 
hour period, but this was compensated for by lower physical activity thermogenesis. Upon 304 
applying this protocol to a cohort of adults with obesity (72), extended fasting resulted in a 305 
slightly greater compensatory increase in energy intake following fasting (although still not 306 
adequate to offset the energy consumed or omitted at breakfast), whilst daily fasting was 307 
again causally related to lower physical activity energy expenditure in the morning. 308 
Interestingly, in this cohort with obesity breakfast did result in improved insulinaemic 309 
responses during an oral glucose tolerance test relative to the fasting condition. However, this 310 
test was aligned for circadian cycle rather than feeding cycle, so the observed finding could 311 
simply reflect better alignment with anticipated events in the breakfast condition. 312 
Other studies have applied time-restricted feeding under eucaloric conditions, much alike the 313 
study of Stote et al. (54). Focusing on energy metabolism, Moro et al. (75) randomised 34 314 
men to 8 weeks of time-restricted feeding or a control diet. Diets were matched for energy 315 
and macronutrient content and aimed to provide 100% of energy requirements across three 316 
meals in both conditions. In the control condition, meals were consumed at 08:00, 13:00 and 317 
20:00, whilst in the experimental condition meals were consumed at 13:00, 16:00 and 20:00 318 
to give a 16-hour fast. The time-restricted approach resulted in reductions in fat mass relative 319 
to controls, which were partnered by decreases in respiratory exchange ratio, indicating a 320 
shift toward fat oxidation. Interestingly, however, despite accompanying reductions in leptin 321 
and hypothalamic-pituitary-thyroid signalling, resting energy expenditure was maintained. 322 
This reinforces the notion that nutrient timing impacts upon nutrient metabolism, whilst also 323 
highlighting that this appears to occur to a greater degree with a 16-hour fast relative to a 12-324 
hour fast. Considering this in light of the typical postprandial nutrient profile discussed 325 
previously, the increase in fasting duration may provide more opportunities for metabolism of 326 
substrates derived from endogenous lipids. This again points to the possibility that routine 327 
extension of the fasting period beyond 12-14 hours may be key to these benefits, which was 328 
not necessarily achieved by the 5:2 or modified alternate-day methods discussed earlier. The 329 
pivotal question is whether these improvements are enhanced with even longer durations of 330 
complete fasting. 331 
More prolonged and complete fasting was recently examined by Sutton et al. (70), who 332 
hypothesised that circadian rhythms in energy metabolism would potentiate the effects of 333 
time-restricted feeding when eating times are confined to earlier stages of the waking phase. 334 
Using a repeated-measures crossover design, they compared the effect of consuming all daily 335 
calories within a 6-hour window and a 12-hour window over 5 weeks in men with pre-336 
diabetes. The diets were prescribed based on energy requirements to maintain energy balance 337 
and were also matched for energy and macronutrient content. Compliance to the two 338 
conditions was high and the extended fasting period was accompanied by reductions in 339 
fasting insulin, peak insulin and insulin resistance during an oral glucose tolerance test. 340 
However, it appears the magnitude and persistence of any treatment effects may have 341 
required a longer wash-out interval between repeated treatments, as the impacts on 342 
insulinaemia were seemingly affected by baseline differences arising from a trial order effect. 343 
Combined with the fact that the fasting duration preceding post-intervention measurements 344 
was not standardised across trials, further investigations are warranted to verify these 345 
intriguing possibilities. 346 
Based on all the above findings, evidence does point to an effect of extended fasting intervals 347 
on fat mass independent of energy balance, particularly when the fasting interval is extended 348 
to at least 16 hours, as shown by Stote et al. (54) and Moro et al. (75). In both cases, this 349 
produced significant reductions in fat mass relative to a routine 12 hour fast, which implicates 350 
extended fasting beyond 12 hours as a key factor. However, the importance of such changes 351 
for metabolic health are less clear due to a series of confounding influences.  352 
Complete Alternate-Day Fasting – Thus far, the intermittent fasting strategies discussed 353 
typically permit the consumption of calories within each 24-hour cycle to some degree, 354 
meaning that the fasting interval is only extended by a few hours (76). This is primarily to 355 
facilitate adherence (32,34) but it also replenishes hepatic glycogen stores and reduces the 356 
utilisation of lipid-derived substrates (i.e. ketone bodies), which may mask several proposed 357 
benefits of intermittent fasting (28). Furthermore, this disruption is profoundly asymmetric, 358 
in that even a short feeding occasion immediately suppresses lipolysis and ketogenesis, which 359 
then do not return for a number of hours (41,42). It is worthy of note at this juncture that the 360 
inclusion of physical activity or exercise during the fasted period may serve to accelerate the 361 
restoration of these pathways to some degree, although the concurrent application of 362 
intermittent fasting alongside exercise interventions is beyond the scope of this review. 363 
Nonetheless, the 20-hour fasting interval used by Stote et al. (54) is likely to have led to a 364 
greater reliance on these lipid-derived substrates over the course of 24 hours, which may 365 
explain the reduction in fat mass despite eucaloric intake. 366 
Building upon this premise, Halberg et al. (47) applied a 20-hour fast on alternate days from 367 
22:00 to 18:00, representing an integration of the strategies employed by Stote et al. (54) and 368 
Varady et al. (32). Fasting prohibited all intake with the exception of water, whilst during the 369 
intervening feeding periods participants were told to double their habitual intake to maintain 370 
body mass. Although dietary intake was not monitored, blood samples collected in a subset 371 
of fasting periods confirmed compliance with the fasting protocol, with corresponding 372 
changes in systemic concentrations of glucose, non-esterified fatty acids, glycerol, 373 
adiponectin and leptin. Although both body mass and fat mass were unchanged, the glucose 374 
infusion rate during a euglycaemic-hyperinsulinemic clamp increased in the final 30 minutes 375 
of the sampling period, suggesting enhanced insulin sensitivity following complete alternate-376 
day fasting. Accordingly, this was accompanied by more rapid suppression of adipose tissue 377 
lipolysis during the insulin infusion. While the lack of an effect on body mass and fat mass 378 
relative to prior studies may reflect the disparity in cumulative fasting time, the authors were 379 
nonetheless able to conclude that this approach to intermittent fasting can improve metabolic 380 
health even in the absence of detectable changes in body mass. 381 
Employing a similar approach, Soeters et al. (77) recruited eight males of healthy weight to a 382 
repeated-measures crossover study. This compared the effects of two weeks of a standard 383 
weight maintenance diet against two weeks of an intermittent fasting diet, using the same 384 
fasting protocol as Halberg et al. (47). In this instance, a more prescriptive approach was 385 
adopted to the feeding cycles, with liquid meals used to bolster intake and adjustment of 386 
prescriptions in the event of meaningful weight change. Accordingly, body mass and 387 
composition were unaltered, yet there were no significant changes in glucose, lipid or protein 388 
kinetics in the basal state, or during a two-stage euglycaemic-hyperinsulinemic clamp. In 389 
actuality, the only difference was a slight decrease in resting energy expenditure following 390 
the intermittent fasting arm. 391 
To the contrary of Halberg et al. (47) and Stote et al. (54), the above findings suggest that 392 
recurrent extension of the fasting period exerts no influence on energy or nutrient 393 
metabolism, aside from a possible decline in resting energy use. Whilst there are some 394 
discrepancies in terms of the approach to feeding cycles and assessment of nutrient 395 
metabolism under dynamic conditions, attributing to such factors would suggest the effect is 396 
unlikely to be clinically meaningful. However, work by Heilbronn and colleagues provides 397 
interesting insights that could explain such stark contrasts between ostensibly similar 398 
approaches (34,78). Their study applied an intermittent fasting intervention to a cohort of 16 399 
adults who were not obese which involved fasting from midnight to midnight on alternating 400 
days for 3 weeks, with fasting periods only permitting energy-free drinks and sugar-free gum 401 
(fed periods were ad libitum). Assessments of body composition, a mixed-meal test and 402 
muscle biopsies were carried out at baseline and follow-up, with an additional set of 403 
measurements collected after a 36-hour fast to explore the physiological impact of individual 404 
fasting periods on energy metabolism. 405 
Although energy intake was not reported, the intervention reduced body mass by 2.5%, 406 
approximately two thirds of which was accounted for by reduced fat mass. However, the 407 
majority of fasting parameters, including plasma glucose concentration, resting metabolic 408 
rate, substrate oxidation and muscle GLUT4 content showed no notable change (34,78). Key 409 
exceptions were sex-specific alterations in cholesterol profile, with women experiencing an 410 
increase in HDL cholesterol concentration and men exhibiting reductions in fasting 411 
triglycerides. Values collected after 36 hours of fasting confirmed increased fatty acid 412 
oxidation, raising the question of why the routine upregulation of fat metabolism combined 413 
with body mass losses resulted in no consistent changes in metabolic health. However, this 414 
pattern of sexual dimorphism continued into postprandial outcomes, with increases in glucose 415 
area under curve for females and reductions in insulin area under curve for males (78). 416 
It might then be suggested that males and females respond differently to complete alternate-417 
day fasting. However, there were a number of baseline differences between men and women 418 
in that study which should be considered in this interpretation, with men exhibiting higher 419 
glucose, insulin and triglyceride concentrations in the fasted state (34). Upon contextualising 420 
this in the physiology of insulin resistance (9–14), it seems plausible that the metabolic state 421 
of male participants at baseline may stand to benefit more from the routine extension of 422 
fasting (notwithstanding the possibility of statistical regression). In these individuals, the shift 423 
toward fat oxidation seen in response to prolonged fasting could help to clear lipid 424 
intermediaries from non-adipose tissues, thereby enhancing insulin sensitivity. This is 425 
supported by the reported increase in CPT1 protein content in muscle tissue after the 426 
intervention (78,79). 427 
Extending this premise to the studies of Halberg et al. (47) and Soeters et al. (77), the 428 
average body fat percentage of their cohorts was 20.1% and 14.8%, respectively. This may 429 
therefore support the notion that those with lower levels of adiposity may not benefit from 430 
such interventions. Consequently, it is imperative to consider the seemingly distinct 431 
responses seen between leaner and more overweight cohorts when interpreting the results of 432 
similar studies. This is not only because the potential for weight loss and health gain may 433 
vary, but also because the presentation as lean or obese at baseline may be symptomatic of a 434 
predisposition towards various compensatory adjustments that predict responsiveness to 435 
treatment (5, 72–74,80). 436 
Furthering this line of enquiry, Catenacci et al. (81) undertook a randomised controlled trial 437 
of complete alternate-day fasting in a sample of adults with obesity. Briefly, 26 participants 438 
were randomised to undertake 8 weeks of either daily calorie restriction (requiring a 439 
reduction in energy intake of 400 kcal∙day-1) or a complete alternate-day fast. The 440 
intermittent fasting condition imposed a fast on every other day and provided a diet to meet 441 
estimated daily energy requirements during feeding periods, with a series of 200 kcal 442 
optional food modules to permit ad libitum intake. All foods were provided and diets were 443 
matched for macronutrient balance rather than energy intake. Consequently, energy intake 444 
across the intervention was lower with the intermittent fasting approach, averaging 53% of 445 
weight maintenance requirements compared to 72% for daily calorie restriction. This was 446 
accompanied by a trend for greater reductions in body mass with intermittent fasting relative 447 
to calorie restriction, with 8.8% and 6.2% reductions seen in the respective conditions. 448 
Despite this, fat mass and lean mass decreased to a similar degree in both groups, a pattern 449 
mirrored by improvements in fasted lipid profile. Only intermittent fasting produced 450 
improvements in fasted glucose concentration from baseline to follow-up, yet responses to a 451 
dynamic test of insulin sensitivity were unaltered. Conversely, resting metabolic rate was 452 
reduced by daily calorie restriction only, following correction for body composition changes, 453 
with a trend for a between-group difference. However, between-group comparisons were 454 
compromised by baseline differences, with those in the daily calorie restriction group 455 
presenting with higher body mass and fasting insulin concentrations on average.   456 
Summary 457 
Intermittent fasting clearly encompasses a broad spectrum of dietary interventions. The 458 
defining characteristic is the confinement of calorie restriction to a specified temporal 459 
window, be that 16 hours each day (75), every other day (32,34), or just two days per week 460 
(61,62). Across these various models, intermittent fasting can elicit reductions in body mass 461 
and improvements in metabolic health, effects which appear broadly comparable to standard 462 
daily calorie restriction (82). However, because the therapeutic potential of these temporal 463 
strategies may lie in routinely extending catabolic periods, thereby increasing reliance on 464 
lipid-derived substrates (28), the similar efficacy in relation to standard approaches could 465 
instead reflect a failure to meaningfully extend the post-absorptive period. The 5:2 diet and 466 
modified alternate-day fasting rarely omit more than one meal in sequence and therefore this 467 
transition to lipid-derived substrates may scarcely be made (58–60,67,68). Conversely, if 468 
applying approaches that extend the fasting interval toward 20 hours and beyond (e.g. 469 
consecutive fasting days in the 5:2 diet or time-restricted feeding), this transition to lipid-470 
derived substrates is likely to be made more frequently, perhaps explaining the proposed 471 
superiority of these approaches (54, 61,62,75). Unfortunately, whilst the latter studies of 472 
complete alternate-day fasting offer amongst the longest uninterrupted fasting periods, the 473 
true effects of this are difficult to isolate due to metabolically diverse samples and the use of 474 
single-arm trials. Consequently, there remains an urgent need for well-designed, randomised-475 
controlled trials of this commonly adopted approach. 476 
Future Directions 477 
Identifying more effective strategies for managing obesity and associated metabolic disorders 478 
remains a public health challenge and intermittent fasting may represent a potent tool. 479 
However, research to support this is scarce and a number of important facets have been 480 
overlooked. Further research is therefore warranted to establish whether intermittent fasting 481 
is simply an alternative means of achieving calorie restriction (76), or a dietary strategy 482 
which offers a favourable method for maintaining/improving metabolic health. 483 
Body Composition – Whilst much investigation has been devoted to the effects intermittent 484 
fasting exerts on fat balance, routinely extending catabolic periods also carries implications 485 
for fat-free mass. Anton et al. (28) argue that the increased reliance on lipid-derived 486 
substrates during prolonged fasting serves to minimise deteriorations in muscle mass and 487 
function, although this does not negate these deteriorations all together. Mechanistically, net 488 
protein balance is a product of constant interactions between protein synthesis and 489 
breakdown (83). Following an overnight fast (approximately 8-12 hours), there is an increase 490 
in amino acid efflux from muscle tissue (84), suggesting  a shift in favour of net muscle 491 
protein breakdown (85–87). Whilst there are limited data to support an exaggeration of this 492 
catabolic state when the fasting duration is extended to 24 hours, a recent study by Vendelbo 493 
et al. (88) showed that fasting for 72 hours doubled the rate of amino acid efflux from 494 
skeletal muscle when compared to a 10-hour fast. Accordingly, it would be reasonable to 495 
anticipate a greater decline in fat-free mass in response to intermittent fasting when compared 496 
to daily calorie restriction.  497 
Contrary to this mechanistic perspective, however, a systematic review of randomised-498 
controlled trials by Varady (89) concluded that intermittent fasting may in fact offer 499 
enhanced retention of fat-free mass when compared to daily calorie restriction. A similar 500 
conclusion was also drawn by a more recent review comparing intermittent approaches with 501 
very-low calorie dieting (90). Whilst the predominance of modified alternate-day fasting 502 
studies in the former review may help to explain this, it is worthy of note that the complete 503 
alternate-day studies of both Halberg et al. (47) and Heilbronn et al. (34) were included. If 504 
verified, enhanced retention of fat-free mass relative to daily calorie restriction would be a 505 
potent asset considering its association with resting metabolic rate (91–93). Consequently, 506 
clarifying the effect of complete alternate-day fasting on fat-free mass should be a central 507 
research priority.  508 
Energy Expenditure – A key (but often overlooked) issue with conventional obesity 509 
management approaches is compensatory changes in other dimensions of energy balance, 510 
particularly decreased energy expenditure with daily calorie restriction (21,22,94). It is not 511 
clear from the existing body of intermittent fasting research whether such compensatory 512 
changes may be invoked. Focusing initially on resting metabolic rate, both Heilbronn et al. 513 
(34) and Catenacci et al. (81) reported no detectable change in response to complete 514 
alternate-day fasting, whilst Soeters et al. (77) suggest a decline in resting energy use of 59 515 
kcal∙day-1. Conversely, physical activity energy expenditure has not been thoroughly and 516 
objectively examined in response to complete alternate-day fasting. Klempel et al. (35) 517 
observed no changes in daily step counts during 8-weeks of modified alternate-day fasting, 518 
despite clinically meaningful weight losses, and ensuing studies employing accelerometers 519 
have verified this outcome (95,96). However, it should be noted that these studies all 520 
employed modified alternate-day fasting approaches, which can reasonably be expected to 521 
differ in their effects on voluntary behaviour relative to complete alternate-day methods. 522 
In the absence of objective measures of energy expenditure, Sutton et al. (70) argue that 523 
energy expenditure is not affected by temporal restrictions of energy intake based on the 524 
absence of significant differences in body mass in their eucaloric time-restricted feeding 525 
study. However, Dhurandhar et al. (56) highlight that accurate determination of energy 526 
balance necessitates measurement of all aspects of the equation. While it does then remain a 527 
distinct possibility that typical compensatory responses to an energy deficit are blunted when 528 
intermittent fasting, a lack of evidence about isolated dimensions of energy expenditure 529 
currently prevents reliable conclusions being drawn. There is therefore definite need to 530 
examine the cumulative impact of intermittent fasting on the components of energy balance 531 
in a reliable and well-controlled manner, not least physical activity thermogenesis. 532 
Postprandial Nutrient Metabolism – An opportunity arising from the pre-existing literature 533 
stems from the fact that the majority of studies have focused on fasting measures of glucose, 534 
insulin and triglycerides, with very few studies employing dynamic tests. The relevance of 535 
this is well-illustrated by the impact of intermittent fasting on insulin; improvements in 536 
fasting insulin have been consistently shown in a number of studies as reviewed by Barnosky 537 
et al. (82). They also show that in a subset of these studies fasting indices of insulin 538 
resistance such as the homeostasis model generally improve following a period of 539 
intermittent fasting. However, it is important to note that while these fasting indices are 540 
useful in easing experimental demands, there are several limitations. For instance, Borai et al. 541 
(97) suggest it is possible for a participant to be insulin resistant without demonstrating 542 
fasting hyperinsulinaemia. 543 
The same inconsistencies emerge when examining postprandial glycaemia, whilst 544 
postprandial lipaemia has been largely ignored. On an acute basis, Antoni et al. (98) 545 
demonstrate that a day of 100% caloric restriction results in enhanced suppression of 546 
postprandial triglyceride and non-esterified fatty acid concentrations, relative to habitual 547 
intake and partial energy restriction. Extending this to the 5:2 approach, a similar pattern 548 
emerged with improvements in postprandial triglyceride levels with the intermittent condition 549 
relative to continuous restriction (62). Such effects are also consistent with the enhanced 550 
suppression of adipose tissue lipolysis reported by Halberg et al. (47). Given the importance 551 
of these outcomes in the context of obesity and the associated comorbidities, closer 552 
examination is warranted. 553 
Comparative Designs – Despite being proposed as an alternative approach to weight loss, 554 
few human trials to date have directly compared complete alternate-day fasting against 555 
standard daily calorie restriction. Although it is generally reported that the outcomes are 556 
similar, the broad spectrum of cohorts and experimental protocols employed confounds 557 
reliable comparisons against the pre-existing literature (89). The study of Catenacci et al. (81) 558 
is certainly an exception to this pattern, as they directly compared complete alternate-day 559 
fasting and daily calorie restriction; however, the two conditions were not matched for the 560 
degree of calorie restriction imposed. For this reason, reaching a consensus on the relative 561 
merits of intermittent fasting is not possible without further studies with appropriate controls. 562 
Fasting-Dependent Effects – Lastly, and perhaps most importantly, is the possibility that 563 
remaining in a post-absorptive state for prolonged periods (i.e. fasting) may impart 564 
independent health benefits beyond the established effects of the net negative energy balance 565 
per se (and thus weight-loss). This is supported by Halberg et al. (47), who propose 566 
significant improvements in insulin sensitivity in response to complete alternate-day fasting; 567 
yet the failure of Soeters et al. (77) to replicate this finding with a near identical fasting 568 
protocol renders current data equivocal. This conflict may be driven by methodological 569 
contrasts in baseline adiposity and the refeeding protocol employed, but it leaves a pertinent 570 
question nonetheless. If fasting-dependent effects on health do exist, are conventional meal 571 
patterns contributing to metabolic disturbances irrespective of calorie content? This would 572 
mean that changes in feeding times could constitute a novel dimension of what is considered 573 
a healthy diet, as opposed to simply being a vehicle for calorie restriction.  574 
In simple terms, nutritional considerations can be broadly classified under the three headings 575 
of type, quantity and timing, with current dietary guidelines such as the Eatwell guide 576 
(99,100) providing a very clear and evidenced illustration of the first two categories (i.e. what 577 
foods we should eat and how much we should eat). Further research is needed to complete the 578 
picture and include recommendations about when we should eat – or choose not to. 579 
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